Chemical preparations for pharmaceutical or medical purposes, namely, for the detection of fibrinogen polymerization disorders, determination of initial thrombin formation by intrinsic activation, determination of factor Xa and factor lla inhibitors and determination of resistance of Factor Va to inactivation by activated protein C (APC) caused by the factor V Leiden mutation (FV:Q506); diagnostic preparations for medical purposes

Diagnostic preparations for clinical or medical laboratory use